Pharsight

Padagis Us patents expiration

1. Clindesse patents expiration

CLINDESSE Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6899890 PADAGIS US Bioadhesive drug delivery system
Apr, 2023

(5 months ago)

US9789057 PADAGIS US Pharmaceutical delivery system
Dec, 2026

(3 years from now)

Drugs and Companies using CLINDAMYCIN PHOSPHATE ingredient

Market Authorisation Date: 30 November, 2004

Treatment: Method of treating bacterial vaginosis

Dosage: CREAM;VAGINAL

How can I launch a generic of CLINDESSE before it's drug patent expiration?
More Information on Dosage

CLINDESSE family patents

Family Patents

2. Evamist patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6978945 PADAGIS US Dispensing device
Jul, 2022

(1 year, 1 month ago)

Drugs and Companies using ESTRADIOL ingredient

Market Authorisation Date: 27 July, 2007

Treatment: NA

Dosage: SPRAY;TRANSDERMAL

More Information on Dosage

EVAMIST family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic